Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Updated

Women living with HIV and using antiretroviral therapy (ART). Women using Non-nucleoside/ nucleotide reverse transcriptase inhibitors (NNRTIs) containing efavirenz can generally use combined hormonal contraceptives (CHCs), progestogen-only pills (POPs), progestogenonly injectables (POIs) (norethisterone enanthate [NETEN])

Notes and Remarks

Some data suggest potential drug interactions between EFV and some hormonal contraceptives. These interactions may reduce the effectiveness of the hormonal contraceptive.